Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Leading Edge Materials' Investor Update and Significant Activities (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  CRDL

Healthcare Biotechnology
Cardiol Therapeutics Inc. is a Canada-based clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead small-molecule drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It holds... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:CRDL)

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders

Newsfile May 29, 2025

Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT

Newsfile May 27, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

Newsfile April 29, 2025

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Newsfile April 16, 2025

Cardiol Therapeutics Announces Year-End 2024 Update on Operations

Newsfile April 1, 2025

Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Newsfile March 3, 2025

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Newsfile February 20, 2025

Cardiol Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Newsfile February 4, 2025

Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

Newsfile November 18, 2024
View More News ››

Opinion & Analysis (TSX:CRDL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:CRDL)

New Issue Priced at $1.60 USD

Whats with Canaccord? They have sever work to do so this can get going. Was told $10 million institutional. Their deals suck as of late.
BeyondValuez - October 9, 2024

Write-up on Cardiol from MicroCap Opportunities

Cardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart Disease https://open.substack.com/pub/microcapopportunities/p/cspi...
rowdyrhino - August 21, 2024

Strong breakouts: CRDL and WELL

CRDL: new Cannacord price target: $8.00 and WELL: TD tgt= $8.00!
Royal10 - June 24, 2024

Whacked!

I've seen junior biotechs get hit on news but this seems extreme to be off 85 cents on a pretty positive NR.Hope it is only a one day...
Hideaway - June 13, 2024

Great positive news out!

This explains the big jump in the last few days. Now, is it sell on news? I certainly hope that this is not the case. GLTA.
Alim33 - June 13, 2024

New 52 week high! $3.84, up more than 15%

Hope not too much profit taking near the end of the day! Don't ruin the momentum!
Alim33 - June 10, 2024
View more Bullboard ››

Graphite One Inc.

Graphite One Inc.

Graphite One Inc. is a Canada-based company, which is focused on developing its Graphite One Project. The Graphite One ...
View More »